GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 208 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q4 2021. The put-call ratio across all filers is 0.56 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $2,608,000 | +208.6% | 81,640 | +234.7% | 0.01% | +250.0% |
| Q1 2022 | $845,000 | +23.0% | 24,395 | +4.0% | 0.00% | +100.0% |
| Q4 2021 | $687,000 | +15.1% | 23,459 | +0.1% | 0.00% | 0.0% |
| Q3 2021 | $597,000 | -27.3% | 23,434 | 0.0% | 0.00% | -50.0% |
| Q2 2021 | $821,000 | +2.2% | 23,434 | +18.9% | 0.00% | 0.0% |
| Q1 2021 | $803,000 | -11.4% | 19,704 | -5.8% | 0.00% | 0.0% |
| Q4 2020 | $906,000 | -24.3% | 20,926 | -3.6% | 0.00% | -33.3% |
| Q3 2020 | $1,197,000 | -86.6% | 21,711 | -84.6% | 0.00% | -85.7% |
| Q2 2020 | $8,914,000 | -24.9% | 141,196 | -39.2% | 0.02% | -34.4% |
| Q1 2020 | $11,865,000 | -31.0% | 232,253 | +7.4% | 0.03% | -11.1% |
| Q4 2019 | $17,197,000 | +76.5% | 216,351 | +7.7% | 0.04% | +71.4% |
| Q3 2019 | $9,742,000 | -20.5% | 200,800 | -13.8% | 0.02% | -19.2% |
| Q2 2019 | $12,260,000 | -14.9% | 233,074 | -14.4% | 0.03% | -18.8% |
| Q1 2019 | $14,409,000 | -1.3% | 272,237 | -23.4% | 0.03% | -11.1% |
| Q4 2018 | $14,599,000 | -18.3% | 355,618 | -24.4% | 0.04% | -2.7% |
| Q3 2018 | $17,877,000 | +1915.4% | 470,449 | +2297.1% | 0.04% | +1750.0% |
| Q2 2018 | $887,000 | +10.2% | 19,626 | +17.7% | 0.00% | 0.0% |
| Q1 2018 | $805,000 | +22.5% | 16,677 | -0.1% | 0.00% | +100.0% |
| Q4 2017 | $657,000 | +24.0% | 16,692 | -2.3% | 0.00% | 0.0% |
| Q3 2017 | $530,000 | +13.5% | 17,082 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $467,000 | +66.2% | 17,082 | +123.6% | 0.00% | 0.0% |
| Q1 2017 | $281,000 | – | 7,639 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HUNTINGTON NATIONAL BANK | 1 | $68 | 0.00% |